SF3B1 and myelodysplastic syndrome: However, the unusual long OS for SF3B1 mutated MDS-EB-2 might be affected by therapy, in this regard allogeneic stem cell transplantation (SCT) received by 3/12 SF3B1mut MDS-EB-2 patients (Supplementary Table S2).